In the BioHarmony Drug Report Database

"Preview" Icon

Sargramostim

Leukine (sargramostim) is a protein pharmaceutical. Sargramostim was first approved as Leukine on 1991-03-05. It is used to treat breast neoplasms, hodgkin disease, neutropenia, non-hodgkin lymphoma, and precursor cell lymphoblastic leukemia-lymphoma in the USA.

 

Trade Name

 

Leukine
 

Common Name

 

sargramostim
 

ChEMBL ID

 

CHEMBL1201670
 

Indication

 

breast neoplasms, hodgkin disease, neutropenia, non-hodgkin lymphoma, precursor cell lymphoblastic leukemia-lymphoma
 

Drug Class

 

Colony-stimulating factors: granulocyte macrophage colony-stimulating factors (GM-CSF)|colony-stimulating factors: macrophage colony-stimulating factors (M-CSF)

Image (chem structure or protein)

Sargramostim structure rendering